Breast Cancer Clinical Trial

Fatigue Intervention Trial for Breast Cancer Survivors

Summary

Thirty to forty percent of breast cancer survivors suffer from persistent fatigue lingering months to years after adjuvant therapy is completed. Although researchers have developed some effective interventions (exercise or group-based holistic program) to treat fatigue, none have addressed the role of the family in the patient's long-term recovery.

The investigators hypothesize that a family-focused intervention in combination with a mind-body group intervention will be more effective in reducing fatigue, improving quality of life, and enhancing family relationships for breast cancer survivors than a group intervention with an individual focus.

View Full Description

Full Description

We propose to address the persistent fatigue experienced by brest cancer survivors by using a 10 week group-based mind body medicine intervention that includes the family in the process. We believe that this family-centered approach can facilitate better communication, create shared illness experience and relieve conflict. Reducing this pervasive source of stress will not only reduce the survivor's fatigue, but also foster an opposite family dynamic with positive effects in many other aspects of post-treatment recovery. We will compare the effectiveness of a 10 week group intervention to a 10 week group intervention that includes a family focus.

Breast cancer survivors with moderate to severe fatigue will be randomly assigned to one of the two groups and we will measure change in fatigue, quality of life, mood and social support from baseline to end-of-program and then two and six months after program completion.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Stage I-III Breast Cancer
At least 3 months since last breast cancer treatment (excluding hormonal therapy or Herceptin).
4 week history of persistent moderate to severe fatigue
Competent to sign informed consent
Willing to be randomized

Exclusion Criteria:

Metastatic breast cancer

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

36

Study ID:

NCT00513136

Recruitment Status:

Completed

Sponsor:

Mercy Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mercy Medical Center
Baltimore Maryland, 21093, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Phase:

Phase 3

Estimated Enrollment:

36

Study ID:

NCT00513136

Recruitment Status:

Completed

Sponsor:


Mercy Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider